Tag: Brinavess
FDA panel votes against approval of AF drug Brinavess
The US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted not to recommend approval for the anti-arrhythmic drug...
AHA 2019: Correvio announces new data from SPECTRUM Brinavess study
Correvio announced the presentation of new data from the SPECTRUM study evaluating Brinavess (vernakalant hydrochloride, IV), an antiarrhythmic drug for the rapid conversion of...